- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Granules India Limited — Important, 20-06-2025: General Updates
20-06-2025 | 04:20 pm
20-06-2025 | 04:20 pm
Granules India has announced a US FDA inspection at its Bonthapally API Unit-I facility, one of the largest single-site Paracetamol API plants globally. The inspection concluded with one observation, which the company will address promptly. The facility also produces Metformin and Guaifenesin APIs, reinforcing Granules' strong manufacturing base in key pharmaceutical ingredients.
No comments yet. Be the first to comment!